The last mile of care isn’t where the work ends — it’s where value begins. The most advanced analytics mean nothing if they can’t be activated by the people delivering care. The post The Last Mile of Care: Why Value-Based Success Starts at the Bedside appeared first on MedCity News.
This brief focuses on consumers’ understanding of health insurance costs and examines existing federal protections that seek to address barriers to understanding the cost of coverage and care, such as price transparency, self-service price estimator tools, and simplifying cost-sharing designs.
This interactive provides the facts on Medicare spending. Medicare, which serves 70 million people and accounts for 14 percent of the federal budget and 21 percent of national health spending, is at the heart of discussions about health expenditures and affordability. Explore data on enrollment growth, Medicare spending trends overall and per person, growth in…
Addressing the burnout demands integrated systems that lighten administrative burdens rather than compound them. The post To Reduce Therapist Burnout and Improve Care, Turn to Longitudinal Data appeared first on MedCity News.
In an environment where speed, equity, and scientific rigor are all imperative, modernizing patient recruitment is no longer a future goal. It is a present necessity. The post Patient Recruitment Reimagined: How AI is Key to Clinical Trial Acceleration appeared first on MedCity News.
This brief explains the limitations of early data in understanding the impact of the expiration of enhanced premiums tax credit on ACA enrollment. It also provides a timeline of when more complete data will become available.
BOGALUSA, La. — Less than a mile from a century-old mill that sustained generations in this small town north of New Orleans, 19-year-old Tajdryn Forbes was shot to death near his mother’s house. She found Forbes face down in the street in August 2023, two weeks before he had planned to move away from the…
A look back at some of the most intriguing statements from Healthcare Innovation interviews in the past year
Gilead Sciences’ Tubulis acquisition brings antibody drug conjugates in clinical development for cancer. Analysts say the Tubulis platform technologies that yielded these ADCs could also help Gilead develop drugs in other therapeutic areas. The post Gilead’s Pipeline Strategy Takes Shape With $3B Acquisition of Cancer Biotech Tubulis appeared first on MedCity News.
Last fall, before being named the senior U.S. health official, Robert F. Kennedy Jr. said the Trump administration would liberate Americans from the FDA’s “aggressive suppression” of vitamins, dietary supplements, and other substances — ending the federal agency’s “war on public health,” as he put it. In fact, the FDA can’t even require that supplements…